Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer

Breast Cancer Research and Treatment

Volumn 89, Issue 3, 2005, Pages 237-241

  Yonemori, Kan ^a   Katsumata, Noriyuki ^a   Uno, Hajime ^b   Matsumoto, Koji ^a   Kouno, Tsutomu ^a   Tokunaga, Shinya ^a   Yamanaka, Yasuhiro ^a   Shimizu, Chikako ^a   Ando, Masashi ^a   Takeuchi, Masahiro ^b   Fujiwara, Yasuhiro ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

Docetaxel; Metastatic breast cancer; Paclitaxel; Predictive factor; Resistance; Taxane

Indexed keywords

DOCETAXEL; PACLITAXEL; ANTINEOPLASTIC AGENT; TAXOID;

ADULT; ANEMIA; ANOREXIA; ARTHRALGIA; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RESISTANCE; CANCER SURVIVAL; CONTROLLED STUDY; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; FATIGUE; FEBRILE NEUTROPENIA; FOLLOW UP; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; METASTASIS; MYALGIA; NAUSEA; NEUROPATHY; NEUTROPENIA; PREDICTION; PRIORITY JOURNAL; SENSORY DYSFUNCTION; STOMATITIS; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT PLANNING; VOMITING; BONE TUMOR; BREAST TUMOR; DISEASE COURSE; DRUG RESISTANCE; FEMALE; LIVER TUMOR; LUNG TUMOR; LYMPH NODE METASTASIS; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SALVAGE THERAPY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BONE NEOPLASMS; BREAST NEOPLASMS; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MIDDLE AGED; PACLITAXEL; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TAXOIDS; TREATMENT OUTCOME;

EID: 21044456009     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-004-2184-0     Document Type: Article

References (25)

1. X Pivot L Asmar GN Hortobagyi 1999 The efficacy of chemotherapy with docetaxel and paclitaxel in anthracycline-reistant breast cancer Int J Oncol 15 381 386
2. JA Sparano 2000 Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials Clin Breast Cancer 1 32 40
3. PB Schiff J Fant SB Horwitz 1979 Promotion of microtubule assembly in vitro by taxol Nature 277 665 667
4. PB Schiff SB Horwitz 1980 Taxol stabilizes microtubules in mouse fibroblast cells Proc Natl Acad Sci USA 77 1561 1565
5. PB Schiff SB Horwitz 1981 Taxol assembles tubuin in the absence of exogenous guanosine 5′-triphospahate or micro tubule-associated proteins Biochemistry 20 3247 3252
6. MA Jordan RJ Toso L Wilson 1993 Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentration Proc Natl Acad Sci USA 90 9552 9556
7. I Ringel SB Horwitz 1991 Studies with RPR 56976 (Taxotere): a semisynthetic analogue of Taxol J Natl Cancer Inst 83 288 291
8. S Haldar A Basu C Croce 1997 Bcl-2 is the guardian of microtuble integrity Cancer Res 57 229 233
9. JF Riou O Petitgenet C Combeau F Lavelle 1994 Cellular uptake and efflux of docetaxel and paclitaxel in P388 cell line Proc Am Assoc Cancer Res 35 385
10. J Verweij M Clavel B Chevallier 1994 Paclitaxel (taxol) and docetaxel (taxotere): not simply two of a kind Ann Oncol 5 495 505
11. J Alexandre P Bleuzen J Bonneterre W Sutherland JL Misset J Guastalla P Viens S Faivre A Chahine M Spielman A Bensmaine M Marty M Mahjoubi E Cvitkovic 2000 Factors predicting for efficacy and safety of docetaxel in a compassionate use cohort of 825 heavily pretreated advanced breast cancer patients J Clin Oncol 18 562 573
12. 2in patients with metastatic breast cancer according to the status of anthracycline resistance J Clin Oncol 19 336 342
13. I Adachi T Watanabe S Takashima M Narabayashi N Horikoshi H Aoyama T Taguchi 1996 A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer Br J Cancer 73 210 216
14. PM Ravdin HAIII Burris G Cook P Eisenberg M Kane WA Bierman J Mortimer E Genevois RE Bellet 1995 Phase II of docetaxel in advanced anthracycline- resistant or anthracenedione-resistant breast cancer J Clin Oncol 13 2879 2885
15. AD Seidman CA Hudis J Albanel W Tong I Tepler V Currie ME Moynahan M Theodoulou M Gollub J Baselga L Norton 1998 Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer J Clin Oncol 16 3353 3361
16. EA Perez CL Vogel DH Irwin JJ Kirshner R Patel 2001 Multicenter phase II trial of weekly paclitaxel in woman with metastatic breast cancer J Clin Oncol 19 4216 4223
17. YC Lin HK Chang CH Wang JS Chen CC Liaw 2000 Single-agent docetaxel in metastatic breast cancer patients pre-treated with anthracycline and paclitaxel: partial cross-resistance between paclitaxel and docetaxel Anti-Cancer Drugs 11 617 621
18. V Valero SE Jones DD Von Hoff DJ Boosner RG Mennel PM Ravadin FA Holmes Z Rahman MW Schottstaedt JK Erban L Esparaza-Guerra RH Earnhart GN Hortobagyi HA BurrisIII 1998 A phase II study of docetaxel in patients with paclitaxel-resitant metastatic breast cancer J Clin Oncol 16 3362 3368
19. T Suzuma T Sakurai G Yoshimura T Umemura T Tamaki Y Naito 2000 paclitaxel-induced remission in docetaxel refractory anthracycline-pretreated metastatic breast cancer Anti-Cancer Drugs 11 569 571
20. M Ishitobi E Shin N Kikkawa 2001 Metastatic breast cancer with resistance to both anthracycline and docetaxel successfully treated with weekly paclitaxel Int J Clin Oncol 6 55 58
21. World Health Organization: WHO Handbook for reporting result of cancer treatment: offset publication 48, World Health Organization, Genova, 1979
22. A Ardizzoni C Manegolod C Debruyne R Gaafar E Buchholz EF Smit P Lianes G ten Velde L Bosquee C Legrand C Neumaier K King 2003 European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer Clin Cancer Res 9 143 150
23. CA Papadimitriou G Fountzilas G Aravantios C Kalofonos LA Moulopoulos E Briassoulis D Gika MA Dimopoulos 2004 Second-line chemotherapy with gemcitabine and cisplatin in paclitaxel-pretreated, platinum-sensitive ovarian cancer patients. A Hellenic Cooperative Oncology Group Study Gynecol Oncol 92 152 159
24. S Sato J Kigawa Y Kanamori H Itamachi T Oishi M Shimada T Iba J Naniwa K Uegaki N Terakawa 2004 Activity of docetaxel in paclitaxel-resistant ovarian cancer cells Cancer Chemother Pharmacol 53 247 252
25. U Vanhoefer S Cao A Harstrick S Seeber YM Rustum 1997 Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpress the multidrug resistance protein (MRP) Ann Oncol 8 1221 1228